226 results on '"Kariminia, Amina"'
Search Results
2. Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease
3. Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study
4. In vitro and ex vivo anti-diabetic and anti-hyperglycemic properties of Zataria multiflora essential oil
5. Elevated ADA2 Enzyme Activity at the Onset of Chronic Graft-versus-Host Disease in Children
6. A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases
7. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD
8. Validating Alpha-Ketoglutarate As a Biomarker for Chronic Graft-Versus-Host Disease in a Separate Pediatric Cohort
9. Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia
10. Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study
11. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells
12. Immunophenotyping characteristics of COVID‐19 patients: Peripheral blood CD8+ HLA‐DR+ T cells as a biomarker for mortality outcome
13. CD56brightCD16– natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
14. NKreg Cells Associated with Lack of cGvHD Can Be Identified as a CD56brightCD16- Immunosuppressive Cell Population
15. Immunophenotyping characteristics of COVID‐19 patients: Peripheral blood CD8+ HLA‐DR+ T cells as a biomarker for mortality outcome.
16. Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens
17. Early and Late Extensive Chronic Graft-versus-Host Disease in Children Is Characterized by Different Th1/Th2 Cytokine Profiles: Findings of the Children's Oncology Group Study ASCT0031
18. Selective Expression of the Vβ14 T Cell Receptor on Leishmania guyanensis-Specific CD8⁺ T Cells during Human Infection
19. Unique Metabolomic Patterns in Day 100 Plasma with Pediatric Late Acute GvHD and Chronic GvHD
20. Characterization of Regulatory CD56bright NK Cells Associated with the Absence of Chronic Graft-Versus-Host Disease
21. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
22. Long term impact of sulfur mustard exposure on peripheral blood mononuclear subpopulations — Sardasht-Iran Cohort Study (SICS)
23. Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study
24. “Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”
25. 348 - Validating Alpha-Ketoglutarate As a Biomarker for Chronic Graft-Versus-Host Disease in a Separate Pediatric Cohort
26. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies
27. A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases
28. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study
29. Circulating mesenchymal stem cells in sulfur mustard-exposed patients with long-term pulmonary complications
30. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population
31. 355 - NKreg Cells Associated with Lack of cGvHD Can Be Identified as a CD56brightCD16- Immunosuppressive Cell Population
32. Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD
33. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis
34. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8 + T lymphocyte activation
35. Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains
36. 318 - Characterization of Regulatory CD56bright NK Cells Associated with the Absence of Chronic Graft-Versus-Host Disease
37. 124 - Unique Metabolomic Patterns in Day 100 Plasma with Pediatric Late Acute GvHD and Chronic GvHD
38. Selective Expression of the Vβ14 T Cell Receptor on Leishmania guyanensis-Specific CD8+ T Cells during Human Infection
39. Recent Thymic Emigrants and Tregs Expressing CD31 and CD45RA Are Decreased at Day 100 and Prognostic for Chronic GvHD in Children: Results From the Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium 1202 Study
40. CD56 bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- versus -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results
41. Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031
42. An Early Naïve T Cell Population Lacking PD1 Expression at Day 100 As A Prognostic Biomarker of Chronic GVHD
43. IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life
44. Erratum to “Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study” [Biol Blood Marrow Transplant 2016;22:1410-1415]
45. Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia
46. 104 - Recent Thymic Emigrants and Tregs Expressing CD31 and CD45RA Are Decreased at Day 100 and Prognostic for Chronic GvHD in Children: Results From the Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium 1202 Study
47. Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD.
48. Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.
49. Th1 Cell Development Induced by Cysteine Proteinases A and B in Localized Cutaneous Leishmaniasis Due to Leishmania guyanensis
50. Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.